Health and Fitness, is important to living a healthy life. Learn the newest research from our Press Releases today.
Distinction Marks Fifth Consecutive Best and Brightest Award for BioMatrix PLANTATION, Fla., Sept. 21, 2023 /PRNewswire/ — BioMatrix Specialty Pharmacy announced today the organization has been recognized with a fifth consecutive “Best and Brightest Companies to Work For in the Nation”…
Tri Lite, a leading provider of innovative lighting solutions, is proud to announce the launch of the DL2GN Gooseneck Loading Dock Light. Engineered with an industry-first “no sag” design, this groundbreaking product sets a new standard for reliability and performance in loading dock illumination.
ELMHURST, Ill., Sept. 21, 2023 /PRNewswire-PRWeb/ — The DL2GN Gooseneck represents Tri Lite’s commitment to pushing the boundaries of innovation and addressing the specific needs of loading dock operations. Designed to provide precise and consistent illumination, the key features of the DL2GN include the “no sag” design, optimal flexibility, enhanced durability and energy efficiency.
RENTON, Wash., Sept. 20, 2023 /PRNewswire/ — Virginia Mason Athletic Center Today, Seahawks star linebacker Bobby Wagner announced the launch of FAST54, an education and fundraising collaboration with the Seattle Seahawks and Virginia Mason Franciscan Health (VMFH). FAST54 uses…
The Consulting Report is pleased to announce The Top 50 Healthcare Consultants and Leaders of 2023.
NEW YORK, Sept. 20, 2023 /PRNewswire-PRWeb/ — The Consulting Report is pleased to announce The Top 50 Healthcare Consultants and Leaders of 2023. The healthcare consulting market is thriving, characterized by record-high transaction values and significant growth projections. Over the next decade, the global healthcare consulting services market is anticipated to achieve an annualized growth rate of 8.2%, reaching a total value of $62.3 billion. This robust expansion can be readily understood due to several compelling factors. The imperative for hospital organizations to undergo substantial transformation, the resumption of initiatives halted during the pandemic, and the mounting costs associated with healthcare treatments have collectively fueled a substantial surge in demand for external guidance in the healthcare sector.
This year’s awardees provide a wide range of solutions to tackle the intricate challenges that confront healthcare providers and health related companies. Their importance to healthcare organizations cannot be overstated, as they adeptly navigate complex regulatory landscapes, optimize processes, reduce costs, and elevate the quality of medicines and patient care, thereby making indispensable contributions to the overall success and sustainability of healthcare institutions worldwide.
Among this year’s distinguished honorees, Roman Salasznyk stands out as the leader of Booz Allen’s life science practice. Salasznyk’s impressive track record includes authoring over 10 peer-reviewed scientific publications and his prior role at Osiris Therapeutics, where he successfully oversaw a multimillion-dollar government contract. Additionally, Venky Ananth, the Global Head of Infosys’ Healthcare industry vertical, has been a driving force behind the remarkable 2X growth of his company’s healthcare business over the past four years. Lastly, Bruce Hamory, a Partner at Oliver Wyman’s Health and Life Sciences Practice, is nationally recognized for his expertise in health delivery redesign. With a background as a former Professor of Medicine at Penn State and prior service as Chief Medical Officer for Geisinger, he played a pivotal role in expanding the Geisinger Clinic’s physician count from 535 to 750.
Please join us in celebrating the accomplishments of The Top 50 Healthcare Consultants and Leaders of 2023.
This year’s awardees include Petra Jantzer (Accenture), Peter Urbanowicz (Alvarez & Marsal), Ernie Brittingham (Russell Reynolds Associates), Jerry Mathews (Atos), Roman Salasznyk (Booz Allen Hamilton Life Science Solutions), Srini Rajamani (Wipro), David Dominguez (Grant Thornton), Stephane Budel (DeciBio Consulting), Venky Ananth (Infosys), Gregory Bell (CRA), Franziska Thomas (Arthur D. Little), Miguel Edwards (DeciBio Consulting), Kris Vilamaa (Mostly Medicaid), Bob Serrano (Kx Advisors), Brad Michel (Accenture), Jacque Myers (Slalom), David Krahe (Russell Reynolds Associates), Alejandro MartCnez (SDG Group Healthcare & Life Sciences), Sarah Eames (Russell Reynolds Associates), Colleen Hall (Crowe), Colin Enderlein (DeciBio Consulting), Nitin Kumar (Tata Consultancy Services), Kia McLain (North Highland), among other notable industry leaders. To view the full list, visit https://www.theconsultingreport.com/
About The Consulting Report
The Consulting Report is a comprehensive source for market research and insights, business news, investment activity, and corporate actions related to the consulting sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on management consulting and the various companies, executives, and investors that make up the sector.
Media Contact
EDITOR, The Consulting Report, 1 609-365-7014, [email protected], https://www.theconsultingreport.com/
SOURCE The Consulting Report
“Navigating healthcare is an essential skill. Empowerment plays a vital role in your journey with kidney disease because it fuels your spirit to take charge of your health. By becoming empowered, you transform from a passive patient into an active advocate, seeking knowledge, making informed decisions, and actively participating in your healthcare.” Says, Lori Hartwell, RSN Founder and President
Key Event Highlights:
To see the full agenda and register go to RSNHope.org/HopeWeek.
RSN would like to thank our 2023 Hope Week sponsors: Akebia Amgen, Ardelyx, AstraZeneca, Fresenius Kidney Care, Eurofins, Horizon and U.S. Renal Care.
The Renal Support Network is a Registered 501(c)(3) Non-profit and serve people throughout the United States.
Lori Hartwell founded Renal Support Network in 1993 to empower people who have kidney disease to become knowledgeable about their illness, proactive in their care, hopeful about their future and make friendships that last a lifetime. Lori suffered kidney failure at the age of two, survived 50+ surgeries and 13 years of dialysis, and is now living with her fourth kidney transplant.
RSN’s hopeful and life-enriching, non-medical programs help people who have kidney disease and their families, whether they are in the early stages of the disease, are on dialysis, or have received a transplant. www.RSNhope.org.
Media Contact
Suzette Maffi, Renal Support Network, 1 (818) 543-0896, [email protected], https://www.rsnhope.org/
SOURCE Renal Support Network
Read the full article on Precision Benefits Group’s website.
Key takeaways from the interview:
If you are a mid-size company considering self-funding, read the article and talk to a qualified advisor.
Media Contact
Robert DeNinno, Precision Benefits Group, 1 215-235-0540, [email protected], https://www.precisionbenefits.com/
Gregg Mills, BDO USA, https://www.bdo.com/
SOURCE Precision Benefits Group
“We are thrilled to announce our latest curriculum tailored specifically for aspiring surgical technologists,” said Shamsah Noorani, CEO of Health Tech Academy. “Our online platform, certified educators, senior mentorship team, and the courses themselves were all designed to prepare students for successful healthcare careers.”
Among the program’s stand-out features is its emphasis on hands-on learning. Students can practice and refine their skills through digital labs, simulations, and other education models that offer a virtual, risk-free environment. Hands-on experience builds student confidence and amplifies aptitude for hire as a natural supplement to core education and assessments.
“Our Surgical Technologist bootcamp represents the next step in our commitment to high-quality education,” said Health Tech Academy Chairman and lead investor Ed Sattar. “We created each feature of this program —from coursework to our career assessment that evaluates your potential—with real students, real people in mind.”
This latest initiative headlines Health Tech Academy’s comprehensive suite of healthcare career certification programs, including online curriculums for aspiring medical assistants, patient care technicians, and medical coders. They remain committed to bridging the gap between medical knowledge and practical skill, in ways that connect students with rewarding healthcare careers without years of university coursework.
Health Tech Academy empowers the future healthcare workforce to provide life-changing opportunities for personal and professional growth.
If you would like more information about the Surgical Technologist bootcamp from Health Tech Academy, or any of their other preparatory healthcare bootcamp programs, visit the Surgical Technology Bootcamp page, or call (855) 590-6601, to learn more.
Media Contact
Shamsah Noorani, Health Tech Academy, 1 512-940-1981, [email protected], https://www.healthtechacademy.org/
SOURCE Health Tech Academy
A growing number of nations in Southeast Asia—including Malaysia, Thailand, Cambodia, and Indonesia—now offer basic medical coverage to their citizens. This trend is leading to fast expanding demand for medical devices, drugs, and diagnostic test kits and reagents, benefiting Western companies marketing their products in the region. These countries will boast higher growth than the world market.
Mexico’s IVD market is worth about $743 million in 2023, and with 3.6% compound annual growth rate (CAGR) the market will reach $886 million in 2028. Growth is supported by continued acceptance of advanced equipment and growing distribution channels. Segments with strong demand include immunoassays, microbiology and histology/cytology.
Saudi Arabia is another emerging IVD player. Trends in the sales of these products will reflect procedures provided by 557 hospitals, 98,400 physicians, and 9,800 clinical laboratories. Driving the IVD market in Saudi Arabia included 4.9 million hospital admissions, 18.3 million inpatient days, 5.4 million surgical procedures, and 188 million outpatient episodes. Health and living standards in Saudi Arabia are very good. About 85% of the population has ready access to medical providers. The market for diagnostics in Saudi Arabia is estimated at $591 million in 2023 and is expected to grow 5.9% annually to $789 million by 2028.
For more information, purchase “The Worldwide Market for In Vitro Diagnostics” here.
About “The Worldwide Market for In Vitro Diagnostics”
This report, The Worldwide Market for In Vitro Diagnostics, now in its 16th Edition, details IVD activity on a global scope. The report looks at the entirety of the in vitro diagnostic market and makes forecasts, accesses trends, and scrutinizes vendor activities.
The report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Meanwhile, market analysis in this report covers world markets for in vitro diagnostics, with an emphasis on the developed areas of the globe—North America, Japan and Western Europe.
The report also covers more than twenty core market segments, including:
Why Kalorama Information?
Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Kalorama Information produces dozens of reports a year. The firm offers a Knowledge Center, which provides access to all published reports.
Kalorama Information’s studies feature independent primary research conducted by experienced analysts. Researchers build their market analysis independently from published databases, validating data with inside industry contacts and extensive secondary research, so you can have confidence that you’re getting your information from the most trusted source in the industry!
Media Contact
Daniel Granderson, Kalorama Information, a Science and Medicine Group Company, 703-778-3080, [email protected], https://kaloramainformation.com/
SOURCE Kalorama Information
Flexible IV bag systems have been in use for many decades. However, with recent regulatory expectations that require a more extensive approach to verifying container closure integrity, highlighted by USP 1207, the ability to effectively test these systems present many unique challenges. The size and fill volume, as well as the placement and quantity of ports, can drastically impact the overall integrity of the package system. While in some cases, technologies documented in USP 1207, such as vacuum decay may still be viable, in cases where these limiting factors play a critical role in method selection, the CS Analytical Team has developed methodologies that can be customized to your specific IV Bag configuration that still offer the ability to use positive controls and validate to specific micron level leak rates. Additionally, CS Analytical remains committed to exploring new technologies and applications in support of container closure integrity testing flexible IV bag systems.
About CS Analytical Laboratory
The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.
Media Contact
Brian Mulhall, CS Analytical, +1-888-571-1207, [email protected], https://csanalytical.com/
SOURCE CS Analytical
NovaBone Products launches a first foot and ankle-specific syringe delivery system for its bioactive glass delivery system.
ALACHUA, Fla., Sept. 18, 2023 /PRNewswire-PRWeb/ — NovaBone Products, leader in synthetic biologics, is pleased to announce the company has made commercially available a new syringe for targeted delivery of its 45S5 bioactive glass putty device for the foot and ankle market. The newly launched syringe comes in both a 2.5cc and a 5cc formulation.
“We are excited to provide our foot and ankle surgeons with a specific solution to deliver our best-in-class synthetic putty to their patients. This is NovaBone’s first product specifically designed for the foot and ankle market. Along with our NovaForm Wound Matrix clearance earlier this year, this shows our commitment to diversifying our portfolio, leveraging our Bioactive Glass manufacturing expertise, and providing surgeons in multiple specialties with solutions best suited for their patients.” said Sean Finnerty, Executive Vice President of Sales and Marketing at NovaBone.
NovaBone’s Putty, cleared by the FDA in 2006, is a highly effective bone graft substitute that closely mimics the mineral composition of natural bone. NovaBone provides an ideal environment for new bone formation, facilitating the integration of graft material and host tissue.
The foot and ankle syringe is commercially available in the US Market. Dr. Charles E. Cook of Dallas, Texas, was the first foot and ankle surgeon to use the new product designed for medical use of bioactive glass.
“I had the opportunity to use the new 2.5cc syringe delivery system in the OR today. The putty met all my needs and expectations. The putty flowed nicely into the osseous defect, and the putty’s viscosity provided a nice tapenade effect, providing hemostasis. I have been using the larger volume delivery system of NovaBone putty in my practice with great success, and these smaller delivery systems are a much-needed addition for diverse applications.”
For more information on the new bioactive glass syringe, contact us today by visiting our website, novabone.com.
About NovaBone
NovaBone, a Halma company, is privately held and based in Florida since 2002. NovaBone developed the first bioactive glass for bone healing offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. It has developed numerous formulations and delivery systems of its patented, bioactive glass technology platform that results in accelerated bone growth. In total, their exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over a decade and used in over a million clinical applications with unparalleled success, validating the safety and efficacy of NovaBone’s technology.
Media Contact
Sean P. Finnerty, NovaBone Products, 1 908 432 3353, [email protected], www.novabone.com
SOURCE NovaBone Products
